MRC1 and neoplasm: This led us to propose a tumoral MMR gene analysis in patients who developed their MSI/dMMR tumor before the age of 60 when no germline variant has been identified; as for patients above 60 y.o., a sporadic tumor is the most likely explanation and does not require further tumor testing [220].